OSTEOPOROSIS

FACTORES DE RIESGO Y CATEGORIZACIÓN FRAX
BIBLIOGRAFÍA
1. Smith EP, Boyd J, Graeme R, et al. Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor
Gene in a Man. N Engl J Med 1994; 331(20):331:1056-61
2. Kobayash S, Inoue S, Hosoi T, et al. Association of bone mineral density with polymorphism of the estrogen
receptor gene. JBMR 1996;11(3)306-11
3. Wang CL, Tang XY, Chen WQ, et al. Osteoporosis International Association of estrogen receptor α gene
polymorphisms with bone mineral density in Chinese women: a meta-analysis Osteoporosis Int 2007;18(3):
295-305
4. Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused
by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80(12):3689-98
5. Osteoporosis, Who’s at risk. International Osteoporosis Foundation http://www.iofbonehealth.org
6. Sociedad Iberoamericana de Osteologia y Metabolismo Mineral(SIBOMM). Consenso Iberomericano de
Osteoporosis 2009. Osteoporosis: Prevención, Diagnóstico y Tratamiento. http://www.iofbonehealth.org
7. Pérez-López F, Pérez-Roncero G, López-Baena M. Ganancia de Masa Osea en la Adolescencia y riesgo
de osteoporosis climatérica. Rev Ecuat Gin Obstet 2009;16(3): 23-8
8. López LM, Grimes DA, Schulz KF, Curtis KM. Steroidal contraceptives: effect on bone fractures in women.
Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD006033. DOI: 10.1002/14651858.
CD006033.pub4.
9. Yamaguchi T, Sugimoto T. Bone Metabolism and fracture risk in type 2 diabetes mellitus. Endoc Jour 2011;
58 (8): 613-24
10. Takkouche B, Montes-Martinez A, Gill S S, Etminan M. Psychotropic medications and the risk of fracture: a
meta-analysis. Drug Safety 2007;30(2):171-84.
11. Brook JS, Balka EB, Zhang C. The Smoking Patterns of Women in their Forties: their relationship to later
osteoporosis. Psychol Rep 2012 ; 110(2): 351–62.
12. Wong P, Christie J, Wark J. The effects of smoking on bone health. Clinical Science (2007) 113, 233-41
13. Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C, Harbour RT, Caldwell LM, Creed G. Exercise
for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic
Reviews 2011, Issue 7. http://onlinelibrary.wiley.com/o/cochrane/cldare/articles/DARE-12007000943/
frame.html
14. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. National Osteoporosis Guideline
Group. Case finding for the management of osteoporosis with FRAX-assessment and intervention
thresholds for the UK. Osteoporos Int 2008;19(10):1395-408
15. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women
from the UK. Osteoporos Int 2008;19(4):389-97
16. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic
fractures. Osteoporos Int 2006 ;17(12):1726-33
17. Leslie WD, Lix LM. Imputation of 10-year osteoporotic fracture rates from hip fractures: a clinical validation
study. Manitoba Bone Density Program. J Bone Miner Res 2010;25(2):388-92
18. Leslie WD, Morin S, Lix LM. A before and after study of fracture risk reporting and osteoporosis treatment
initiation. Ann Intern Med 2010;153(9):580-6
OSTEOPOROSIS 2015 107